Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis
A Rossini, A Ravaggi, L Biasi, E Agostinelli, L Bercich, G B Gazzola, F Callea, E Radaeli, E Cariani – 30 December 2003 – Hepatitis C virus (HCV) carriers with normal aminotransferase levels often show histological chronic hepatitis. This study was undertaken to determine the effect of interferon (IFN) in such patients. Nineteen HCV carriers with normal aminotransferase activities and chronic hepatitis were randomized to receive IFN‐α2b (3 million units 3 times weekly for 12 months) or no treatment. Therapy was monitored by qualitative and quantitative determination of viral RNA.